-
1.
公开(公告)号:US20170202789A1
公开(公告)日:2017-07-20
申请号:US15326016
申请日:2015-07-16
申请人: Frederick A. Sexton , Timothy S. Tracy , Sitaraman Krishnan , Vankat K. Vendra , James M. Myrick
发明人: Frederick A. Sexton , Timothy S. Tracy , Sitaraman Krishnan , Vankat K. Vendra , James M. Myrick
IPC分类号: A61K31/155 , A61K31/198 , A61K31/22 , A61K9/16 , A61K31/519 , A61K31/522 , A61K31/7072 , A61K31/7004 , A61K31/4164
CPC分类号: A61K31/155 , A61K9/1652 , A61K31/198 , A61K31/22 , A61K31/4164 , A61K31/519 , A61K31/522 , A61K31/7004 , A61K31/7072
摘要: The present invention relates to methods and compositions for improved drug bioavailability and disease treatment, including treatment of diseases related to hormone modulation or CNS function. In certain embodiments, the instant invention provides methods for hormone modulation or improving CNS function, comprising administering to a subject in need thereof a composition comprising one or more hydrogel particles, wherein the one or more hydrogel particles are non-toxic and incorporate at least one active agent, wherein the one or more hydrogel particles release the active agent in a time-controlled and sustained manner in vivo.